← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

NATR logoNature's Sunshine Products, Inc.(NATR)Earnings, Financials & Key Ratios

NATR•NASDAQ
$24.55
$430M mkt cap·23.2× P/E·Price updated May 7, 2026
SectorConsumer DefensiveIndustryPackaged FoodsSub-IndustryNutrition and functional foods
AboutNature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.Show more
  • Revenue$480M+5.7%
  • EBITDA$39M+12.5%
  • Net Income$20M+153.7%
  • EPS (Diluted)1.06+165.0%
  • Gross Margin69.54%-2.7%
  • EBITDA Margin8.04%+6.4%
  • Operating Margin5.15%+16.5%
  • Net Margin4.07%+140.0%
  • ROE12.1%+152.1%
  • ROIC20.96%+27.0%
  • Debt/Equity0.12+32.6%
  • Interest Coverage252.48+98.5%
Technical→

NATR Key Insights

Nature's Sunshine Products, Inc. (NATR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 85 (top 15%)
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Efficient asset utilization: 1.8x turnover

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

NATR Price & Volume

Nature's Sunshine Products, Inc. (NATR) stock price & volume — 10-year historical chart

Loading chart...

NATR Growth Metrics

Nature's Sunshine Products, Inc. (NATR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years3.99%
5 Years4.5%
3 Years4.4%
TTM7.26%

Profit CAGR

10 Years2.89%
5 Years-1.76%
3 Years-
TTM96.52%

EPS CAGR

10 Years3.25%
5 Years-0.19%
3 Years-
TTM106.38%

Return on Capital

10 Years10.12%
5 Years13.01%
3 Years12.16%
Last Year13.83%

NATR Recent Earnings

Nature's Sunshine Products, Inc. (NATR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
Mar 10, 2026
EPS
$0.30
Est $0.18
+62.2%
Revenue
$124M
Est $122M
+1.9%
Q4 2025
Nov 6, 2025
EPS
$0.36
Est $0.19
+89.5%
Revenue
$128M
Est $122M
+5.5%
Q3 2025
Jul 31, 2025
EPS
$0.35
Est $0.18
+94.4%
Revenue
$115M
Est $119M
-3.9%
Q2 2025
May 6, 2025
EPS
$0.25
Est $0.17
+47.1%
Revenue
$113M
Est $114M
-1.0%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 10, 2026
$0.30vs $0.18+62.2%
$124Mvs $122M+1.9%
Q4 2025Nov 6, 2025
$0.36vs $0.19+89.5%
$128Mvs $122M+5.5%
Q3 2025Jul 31, 2025
$0.35vs $0.18+94.4%
$115Mvs $119M-3.9%
Q2 2025May 6, 2025
$0.25vs $0.17+47.1%
$113Mvs $114M-1.0%
Based on last 12 quarters of dataView full earnings history →

NATR Peer Comparison

Nature's Sunshine Products, Inc. (NATR) competitors in Nutrition and functional foods — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
USNA logoUSNAUSANA Health Sciences, Inc.Direct Competitor359.17M19.4633.558.28%1.16%1.84%0.02
NUS logoNUSNu Skin Enterprises, Inc.Direct Competitor345.22M7.022.21-14.26%10.79%20.36%0.45
NHTC logoNHTCNatural Health Trends Corp.Direct Competitor35.71M3.20-41.72-7.42%-3.03%-4.88%0.13
MTEX logoMTEXMannatech, IncorporatedDirect Competitor8.88M4.673.54-10.68%-1.5%-23.83%0.78
HLF logoHLFHerbalife Nutrition Ltd.Product Competitor1.5B14.496.590.89%4.67%
PLBY logoPLBYPlayboy, Inc.Product Competitor188.41M1.67-12.854.13%-10.48%-247.79%1.30
AGEN logoAGENAgenus Inc.Product Competitor132.45M3.75-1102.9410.37%0.1%
NBIX logoNBIXNeurocrine Biosciences, Inc.Supply Chain15.01B149.5932.0321.45%21.55%21.64%0.13

Compare NATR vs Peers

Nature's Sunshine Products, Inc. (NATR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs USNA

Most directly comparable listed peer for NATR.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare NATR against a more recognizable public peer.

Peer Set

Compare Top 5

vs USNA, NUS, NHTC, MTEX

NATR Income Statement

Nature's Sunshine Products, Inc. (NATR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue342.03M364.81M362.21M385.2M444.08M421.91M445.32M454.36M480.14M489.79M
Revenue Growth %0.26%6.66%-0.71%6.35%15.29%-4.99%5.55%2.03%5.67%7.26%
Cost of Goods Sold91.04M95.69M93.94M101.28M115.47M122.15M124.19M129.68M146.26M147.53M
COGS % of Revenue26.62%26.23%25.93%26.29%26%28.95%27.89%28.54%30.46%-
Gross Profit
250.99M▲ 0%
269.12M▲ 7.2%
268.27M▼ 0.3%
283.93M▲ 5.8%
328.62M▲ 15.7%
299.76M▼ 8.8%
321.13M▲ 7.1%
324.69M▲ 1.1%
333.88M▲ 2.8%
342.26M▲ 0%
Gross Margin %73.38%73.77%74.07%73.71%74%71.05%72.11%71.46%69.54%69.88%
Gross Profit Growth %0.31%7.22%-0.31%5.84%15.74%-8.78%7.13%1.11%2.83%-
Operating Expenses249.6M263.77M252.15M262.45M293.95M283.5M302.38M304.59M309.14M277.25M
OpEx % of Revenue72.98%72.3%69.61%68.13%66.19%67.19%67.9%67.04%64.38%-
Selling, General & Admin249.6M263.77M252.15M262.45M293.95M283.5M302.38M304.59M178.39M291.1M
SG&A % of Revenue72.98%72.3%69.61%68.13%66.19%67.19%67.9%67.04%37.15%-
Research & Development3.4M2.8M0001.5M01.7M1.9M0
R&D % of Revenue0.99%0.77%---0.36%-0.37%0.4%-
Other Operating Expenses0-2.15M000-1.5M0-1.7M128.85M-1000K
Operating Income
1.39M▲ 0%
5.35M▲ 285.8%
16.13M▲ 201.3%
21.48M▲ 33.2%
34.67M▲ 61.4%
16.26M▼ 53.1%
18.75M▲ 15.3%
20.09M▲ 7.2%
24.74M▲ 23.1%
28.12M▲ 0%
Operating Margin %0.41%1.47%4.45%5.58%7.81%3.85%4.21%4.42%5.15%5.74%
Operating Income Growth %-86.18%285.8%201.35%33.22%61.39%-53.11%15.32%7.18%23.13%-
EBITDA10.02M15.25M26.72M32.23M45.83M31.94M30.57M34.31M38.59M38.46M
EBITDA Margin %2.93%4.18%7.38%8.37%10.32%7.57%6.86%7.55%8.04%7.85%
EBITDA Growth %-32.5%52.19%75.23%20.58%42.23%-30.31%-4.3%12.27%12.45%6.24%
D&A (Non-Cash Add-back)8.63M9.9M10.6M10.74M11.16M15.68M11.82M14.22M13.84M10.35M
EBIT1.39M3.59M15.69M22.92M32.07M15.46M20.27M18.57M24.74M17.61M
Net Interest Income-145K-387K219K69K216K-126K483K31K-98K217K
Interest Income144K0262K171K466K123K552K177K0268K
Interest Expense289K387K43K102K250K249K69K146K98K16K
Other Income/Expense1.83M-2.15M-483K1.34M-2.85M-1.04M1.45M-1.67M5.07M2.74M
Pretax Income
3.22M▲ 0%
3.2M▼ 0.7%
15.64M▲ 388.8%
22.82M▲ 45.9%
31.82M▲ 39.4%
15.21M▼ 52.2%
20.2M▲ 32.8%
18.43M▼ 8.8%
29.81M▲ 61.8%
30.86M▲ 0%
Pretax Margin %0.94%0.88%4.32%5.92%7.17%3.61%4.54%4.06%6.21%6.3%
Income Tax17.04M4.4M8.71M-137K1.61M14.66M3.79M10.53M9.36M10.17M
Effective Tax Rate %528.83%137.56%55.7%-0.6%5.08%96.39%18.74%57.17%31.4%32.97%
Net Income
-12.94M▲ 0%
-854K▲ 93.4%
6.76M▲ 892.2%
21.34M▲ 215.4%
28.85M▲ 35.2%
-390K▼ 101.4%
15.08M▲ 3965.6%
7.7M▼ 49.0%
19.52M▲ 153.7%
19.89M▲ 0%
Net Margin %-3.78%-0.23%1.87%5.54%6.5%-0.09%3.39%1.69%4.07%4.06%
Net Income Growth %-705.05%93.4%892.15%215.4%35.23%-101.35%3965.64%-48.95%153.65%96.52%
Net Income (Continuing)-13.82M-1.2M6.93M22.96M30.21M550K16.42M7.89M20.45M20.68M
Discontinued Operations0000000000
Minority Interest411K63K227K1.85M3.2M4.14M5.48M5.68M00
EPS (Diluted)
-0.69▲ 0%
-0.04▲ 93.5%
0.34▲ 860.6%
1.07▲ 214.7%
1.42▲ 32.7%
-0.02▼ 101.4%
0.77▲ 3950.0%
0.40▼ 48.1%
1.06▲ 165.0%
1.11▲ 0%
EPS Growth %-727.27%93.52%860.63%214.71%32.71%-101.41%3950%-48.05%165%106.38%
EPS (Basic)-0.69-0.040.351.091.45-0.020.790.411.08-
Diluted Shares Outstanding18.88M19.12M19.66M19.97M20.33M19.33M19.47M18.62M18.47M17.93M
Basic Shares Outstanding18.76M19.12M19.31M19.54M19.86M19.33M19.07M18.62M18M17.52M
Dividend Payout Ratio----68.82%-----

NATR Balance Sheet

Nature's Sunshine Products, Inc. (NATR) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets102.51M106.83M112.7M154.06M164.67M149.51M165.82M160.58M178.84M178.59M
Cash & Short-Term Investments42.91M50.64M53.63M92.07M86.18M60.03M82.37M84.7M93.89M87.58M
Cash Only42.91M50.64M53.63M92.07M86.18M60.03M82.37M84.7M93.89M87.58M
Short-Term Investments0000000000
Accounts Receivable8.89M7.75M7.32M7.38M8.87M14.11M8.83M9.48M8.6M12.55M
Days Sales Outstanding9.487.757.386.997.2912.27.237.616.549.18
Inventory44.05M42.05M46.67M47.68M60.85M67.95M66.89M59.44M68.31M67.13M
Days Inventory Outstanding176.6160.39181.32171.85192.36203.04196.6167.31170.47168.3
Other Current Assets998K00007.42M7.72M6.96M8.04M11.33M
Total Non-Current Assets92.69M86.19M100.36M95.43M94.21M80.27M83.96M80.28M82.3M82.87M
Property, Plant & Equipment69.11M64.06M83.46M74.56M69.21M62.31M58.36M52.38M50.52M51.79M
Fixed Asset Turnover4.95x5.69x4.34x5.17x6.42x6.77x7.63x8.67x9.50x9.83x
Goodwill0000000000
Intangible Assets709K618K567K0000000
Long-Term Investments1.98M1.31M0000001.13M2.41M
Other Non-Current Assets12.61M11.15M11.43M12.18M11.41M11.11M10.53M10.25M10.59M43.89M
Total Assets
195.19M▲ 0%
193.02M▼ 1.1%
213.07M▲ 10.4%
249.5M▲ 17.1%
258.87M▲ 3.8%
229.78M▼ 11.2%
249.77M▲ 8.7%
240.85M▼ 3.6%
261.15M▲ 8.4%
261.46M▲ 0%
Asset Turnover1.75x1.89x1.70x1.54x1.72x1.84x1.78x1.89x1.84x1.88x
Asset Growth %-5.05%-1.12%10.39%17.1%3.76%-11.24%8.7%-3.57%8.42%27.9%
Total Current Liabilities53.66M66.69M57.95M69.65M76.67M65.58M76.75M65.69M78.54M71.37M
Accounts Payable4.21M5.22M4.41M6.49M9.7M6.35M7.91M8.91M8.02M8.25M
Days Payables Outstanding16.919.9117.1223.3830.6718.9723.2525.0820.0220.61
Short-Term Debt506K1.53M1.52M2.51M1.55M1.17M003.27M4.37M
Deferred Revenue (Current)3.35M1.2M1.27M2.09M3.69M2.25M1.79M2.77M5.84M21.66M
Other Current Liabilities14.69M18.87M11.27M15.29M15.03M7.79M17.05M11.16M56.7M64.22M
Current Ratio1.91x1.60x1.94x2.21x2.15x2.28x2.16x2.44x2.28x2.28x
Quick Ratio1.09x0.97x1.14x1.53x1.35x1.24x1.29x1.54x1.41x1.41x
Cash Conversion Cycle169.19148.23171.57155.46168.98196.27180.59149.84156.99156.88
Total Non-Current Liabilities21.81M5.76M25.68M22.61M20.8M17.15M13.48M14.17M21.05M23.18M
Long-Term Debt13.18M002.42M1.17M000018.06M
Capital Lease Obligations0020.21M16.41M15.92M13.74M10.38M10.28M15.63M36.32M
Deferred Tax Liabilities770K1.56M1.66M1.39M1.57M1.44M1.4M1.01M954K3.84M
Other Non-Current Liabilities7.86M4.21M3.82M2.39M2.14M1.97M1.7M2.89M4.47M15.8M
Total Liabilities75.46M72.45M83.63M92.26M97.47M82.73M90.23M79.86M99.59M94.54M
Total Debt13.69M1.53M26.67M26.33M22.99M19.18M14.92M14.2M18.9M22.43M
Net Debt-29.22M-49.11M-26.96M-65.74M-63.2M-40.85M-67.45M-70.5M-74.99M-65.15M
Debt / Equity0.11x0.01x0.21x0.17x0.14x0.13x0.09x0.09x0.12x0.12x
Debt / EBITDA1.37x0.10x1.00x0.82x0.50x0.60x0.49x0.41x0.49x0.58x
Net Debt / EBITDA-2.92x-3.22x-1.01x-2.04x-1.38x-1.28x-2.21x-2.05x-1.94x-1.94x
Interest Coverage4.80x9.27x364.77x224.74x128.29x62.10x293.78x127.21x252.48x1100.81x
Total Equity
119.73M▲ 0%
120.57M▲ 0.7%
129.44M▲ 7.4%
157.23M▲ 21.5%
161.4M▲ 2.7%
147.05M▼ 8.9%
159.54M▲ 8.5%
160.99M▲ 0.9%
161.55M▲ 0.3%
166.92M▲ 0%
Equity Growth %-9.57%0.7%7.36%21.48%2.65%-8.9%8.5%0.91%0.35%7.41%
Book Value per Share6.346.306.587.877.947.618.208.658.759.31
Total Shareholders' Equity119.32M120.5M129.21M155.39M158.2M142.91M154.06M155.31M161.55M166.92M
Common Stock131.53M133.68M135.74M139.31M133.38M121.58M119.69M114.58M102.19M102.25M
Retained Earnings-2.07M-2.07M4.69M26.03M35.02M34.63M49.71M57.41M76.93M82.05M
Treasury Stock0000000000
Accumulated OCI-10.13M-11.11M-11.22M-9.96M-10.21M-13.31M-15.35M-16.67M-17.57M-17.38M
Minority Interest411K63K227K1.85M3.2M4.14M5.48M5.68M00

NATR Cash Flow Statement

Nature's Sunshine Products, Inc. (NATR) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations10.52M21.83M8.54M37.66M34.61M710K41.23M25.3M35.32M35.32M
Operating CF Margin %3.08%5.98%2.36%9.78%7.79%0.17%9.26%5.57%7.36%-
Operating CF Growth %207.99%107.46%-60.86%340.71%-8.1%-97.95%5706.48%-38.64%39.62%135.11%
Net Income-13.82M-1.2M6.93M22.96M30.21M550K15.08M7.89M019.89M
Depreciation & Amortization8.63M9.81M10.6M10.74M11.16M11M11.82M14.22M0-275K
Stock-Based Compensation2.22M2.17M2.12M3.79M3.73M2.9M4.89M4.79M0339K
Deferred Taxes14.13M-18K4.28M-4.36M-4.13M6.6M-8.53M-1.66M02.66M
Other Non-Cash Items-1.93M-778K6.31M3.73M8.38M6.97M4.79M8.52M38.41M22.11M
Working Capital Changes1.29M11.86M-21.69M793K-14.74M-27.32M13.18M-8.46M-3.09M5.79M
Change in Receivables-1.24M189K375K106K-1.68M-5.94M4.92M-1.12M1.01M-2.31M
Change in Inventory5.18M1.07M-4.87M-154K-14.46M-8.84M995K5.56M-7.82M5.5M
Change in Payables-1.12M1.03M-960K2.09M3.08M-2.8M1.42M1.08M-1.8M359K
Cash from Investing-3.2M211K-5.1M-4.91M-6.61M-7.63M-10.48M-10.97M-12.64M-14.01M
Capital Expenditures-5.5M-4.83M-5.1M-4.91M-6.67M-7.63M-10.48M-10.97M-6.48M-1.37M
CapEx % of Revenue1.61%1.33%1.41%1.27%1.5%1.81%2.35%2.41%1.35%-
Acquisitions521K5.04M000000-6.16M-6.16M
Investments----------
Other Investing521K5.04M2K054K0000-6.3M
Cash from Financing1.57M-12.19M-63K3.88M-31.72M-16.25M-7.96M-9.9M-17.61M-18.46M
Debt Issued (Net)3.77M-12.18M03.41M-2.2M-1.55M-1.17M000
Equity Issued (Net)0000-7.42M-13.57M-6.4M-8.86M-16.31M476K
Dividends Paid-1.85M000-19.86M00000
Share Repurchases0000-7.42M-13.57M-6.4M-8.86M-16.31M-24K
Other Financing-347K-11K-63K472K-2.23M-1.13M-385K-1.05M-1.3M-18.93M
Net Change in Cash
10.63M▲ 0%
7.73M▼ 27.3%
2.99M▼ 61.3%
38.44M▲ 1185.2%
-5.88M▼ 115.3%
-26.15M▼ 344.4%
22.34M▲ 185.4%
2.33M▼ 89.6%
9.19M▲ 295.0%
1.09M▲ 0%
Free Cash Flow
5.02M▲ 0%
17M▲ 238.4%
3.44M▼ 79.8%
32.75M▲ 851.9%
27.94M▼ 14.7%
-6.92M▼ 124.8%
30.75M▲ 544.5%
14.33M▼ 53.4%
28.84M▲ 101.3%
23.02M▲ 0%
FCF Margin %1.47%4.66%0.95%8.5%6.29%-1.64%6.9%3.15%6.01%4.7%
FCF Growth %161.86%238.42%-79.76%851.87%-14.69%-124.76%544.46%-53.41%101.31%32.85%
FCF per Share0.270.890.171.641.37-0.361.580.771.561.56
FCF Conversion (FCF/Net Income)-0.81x-25.57x1.26x1.76x1.20x-1.82x2.73x3.29x1.81x1.16x
Interest Paid257K397K64K86K202K264K539K119K98K83K
Taxes Paid4.6M3.54M6.86M4.83M202K5.61M9.26M14.79M12.55M10.67M

NATR Key Ratios

Nature's Sunshine Products, Inc. (NATR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)-10.27%-0.71%5.41%14.89%18.11%-0.25%9.83%4.8%12.1%12.08%
Return on Invested Capital (ROIC)1.04%4.96%13.91%16.61%27.41%11.93%14.18%16.51%20.96%20.96%
Gross Margin73.38%73.77%74.07%73.71%74%71.05%72.11%71.46%69.54%69.88%
Net Margin-3.78%-0.23%1.87%5.54%6.5%-0.09%3.39%1.69%4.07%4.06%
Debt / Equity0.11x0.01x0.21x0.17x0.14x0.13x0.09x0.09x0.12x0.12x
Interest Coverage4.80x9.27x364.77x224.74x128.29x62.10x293.78x127.21x252.48x1100.81x
FCF Conversion-0.81x-25.57x1.26x1.76x1.20x-1.82x2.73x3.29x1.81x1.16x
Revenue Growth0.26%6.66%-0.71%6.35%15.29%-4.99%5.55%2.03%5.67%7.26%

NATR SEC Filings & Documents

Nature's Sunshine Products, Inc. (NATR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 7, 2026·SEC

Material company update

Mar 10, 2026·SEC

Material company update

Nov 6, 2025·SEC

10-K Annual Reports

3
FY 2026

Mar 10, 2026·SEC

FY 2025

Mar 11, 2025·SEC

FY 2024

Mar 12, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Jul 31, 2025·SEC

NATR Frequently Asked Questions

Nature's Sunshine Products, Inc. (NATR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Nature's Sunshine Products, Inc. (NATR) reported $489.8M in revenue for fiscal year 2025. This represents a 97% increase from $249.0M in 1996.

Nature's Sunshine Products, Inc. (NATR) grew revenue by 5.7% over the past year. This is steady growth.

Yes, Nature's Sunshine Products, Inc. (NATR) is profitable, generating $19.9M in net income for fiscal year 2025 (4.1% net margin).

Dividend & Returns

Nature's Sunshine Products, Inc. (NATR) has a return on equity (ROE) of 12.1%. This is reasonable for most industries.

Nature's Sunshine Products, Inc. (NATR) generated $23.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More NATR

Nature's Sunshine Products, Inc. (NATR) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.